Sunday April 5, 2020

Jazz shares fall on public offering

UPDATE: Jazz Pharmaceuticals Plc, maker of the narcolepsy medicine Xyrem, declined in New York trading after the company reported a public offering of 7.88 million shares by some stockholders.

6th March, 2012

Jazz Pharmaceuticals Plc, maker of the narcolepsy medicine Xyrem, declined in New York trading after the company reported a public offering of 7.88 million shares by some stockholders.

Jazz dropped 3.5 per cent to $49.55 in early trading. The shares of the Dublin-based company had gained 89 per cent in the 12 months before today. The drugmaker also has offices in Palo Alto, California, and Philadelphia.

Barclays Plc and Citigroup Inc. are leading the offering, Jazz said yesterday in a...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 3 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago